Articoli anno 2000
Randomized
controlled trial of interferon treatment for advanced hepatocellular carcinoma
Llovet JM, Sala M, Castells L, Suarez Y, Vilana R, Bianchi L, Ayuso C, Vargas
V, Rodes J, Bruix J Liver Unit, BCLC (Barcelona-Clinic Liver Cancer) Group,
IDIBAPS (Institut d'Invertigacions Biomediques August Pi i Sunyer) Hospital
Clinic Barcelona, Barcelona, Spain. Hepatology 2000 Jan;31(1):54-8
Intraoperative
and percutaneous radiofrequency thermal ablation in the treatment of hepatocellular
carcinoma
Nicoli N, Casaril A, Marchiori
L, Mangiante G, Marini G, Colombari R, Portuese A, Hasheminia AR Department
of Surgical and Gastroenterological Sciences, University of Verona. Chir Ital
2000 Jan-Feb;52(1):29-40
What
patients can survive disease free after complete resection for hepatocellular
carcinoma?: A multivariate analysis
Takata M, Yamanaka N, Tanaka T, Yamanaka J, Maeda S, Okamoto E, Yasojima H,
Uematsu K, Watanabe H, Uragari Y First Department of Surgery, Hyogo College
of Medicine, Nishinomiya, Japan. Jpn J Clin Oncol 2000 Feb;30(2):75-81
Predictive
factors for intrahepatic recurrence after percutaneous ethanol injection therapy
for small hepatocellular carcinoma
Koda M, Murawaki Y, Mitsuda A, Ohyama K, Horie Y, Suou T, Kawasaki
H, Ikawa S Department of Clinical Laboratory Medicine, Tottori University, Tottori,
Japan. Cancer 2000 Feb 1;88(3):529-37
Influence
of hepatitis delta virus infection on morbidity and mortality in compensated
cirrhosis type B
The European Concerted Action on Viral Hepatitis (Eurohep). Fattovich G, Giustina
G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW Servizio Autonomo
Clinicizzato di Gastroenterologia, University of Verona, Italy. Gut 2000 Mar;46(3):420-6
Gene
therapy for liver cirrhosis
Fujimoto J First Department of Surgery, Hyogo College of Medicine,
Nishinomiya, Japan. J Gastroenterol Hepatol 2000 Mar;15 Suppl:D33-6
Hepatocellular
carcinoma: radio-frequency ablation of medium and large lesions
Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Ierace T, Solbiati L, Gazelle
GS Department of Radiology, Ospedale Civile, Vimercate, Italy. Radiology 2000
Mar;214(3):761-8
Effects
of prostaglandin E1 administration during hepatectomy for cirrhotic hepatocellular
carcinoma
Hanazaki K, Kajikawa S, Fujimori Y, Nakata S, Shimozawa N, Koide N, Adachi W,
Amano J Second Department of Surgery, Shinshu University School of Medicine,
Matsumoto, Japan. Hepatogastroenterology 2000 Mar-Apr;47(32):461-4
Multiple
macroregenerative nodules in liver cirrhosis due to Budd-Chiari syndrome. Case
reports and review of the literature
Zhou H, Wolff M, Pauleit D, Fischer HP, Pfeifer U Department of Pathology, University
of Bonn, Germany. Hepatogastroenterology 2000 Mar-Apr;47(32):522-7
Primary
liver resection and salvage transplantation or primary liver transplantation
in patients with single, small hepatocellular carcinoma and preserved liver
function: an outcome-oriented decision analysis
Majno PE, Sarasin FP, Mentha G, Hadengue A Transplantation Unit, Department
of Surgery, University Hospital, Geneva, Switzerland. Hepatology 2000 Apr;31(4):899-906
Prospective
validation of the CLIP score: a new prognostic system for patients with cirrhosis
and hepatocellular carcinoma
The Cancer of the Liver Italian Program (CLIP) Investigators.
Hepatology 2000 Apr;31(4):840-5
Fractional
allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma
development during follow-up
Roncalli M, Bianchi P, Grimaldi GC, Ricci D, Laghi L, Maggioni M, Opocher E,
Borzio M, Coggi G Departments of Pathology and Research Laboratories, Humanitas
Clinical Institute of Rozzano, Milan, Italy. Hepatology 2000 Apr;31(4):846-50
Natural
History of Hepatitis C: Its Impact on Clinical Management
Di BisceglieAdrian M. From the Division of Gastroenterology and
Hepatology, Saint Louis University School of Medicine, St. Louis, MO. Hepatology,
April 2000, p. 1014-1018, Vol. 31, No. 4
Better
post-resectional survival in female cirrhotic patients with hepatocellular carcinoma
Lee CC, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, Hshia CY, Wu CW Department
of Surgery, Veterans General Hospital-Taipei, Taiwan.Hepatogastroenterology
2000 Mar-Apr;47(32):446-9
Role
of serum C-reactive protein as a marker of hepatocellular carcinoma in patients
with cirrhosis
Lin ZY, Wang LY, Yu ML, Chen SC, Chuang WL, Hsieh MY, Tsai JF, Chang WY Department
of Internal Medicine, Kaohsiung Medical University Hospital, Taiwan, Republic
of China. J Gastroenterol Hepatol 2000 Apr;15(4):417-21
Simultaneous
measurements of serum alpha-fetoprotein and protein induced by vitamin K absence
for detecting hepatocellular carcinoma
South Tohoku District Study Group. Ishii M, Gama H, Chida N, Ueno Y, Shinzawa
H, Takagi T, Toyota T, Takahashi T, Kasukawa R Third Department of Internal
Medicine, Tohoku University School of Medicine, Sendai, Japan. Am J Gastroenterol
2000 Apr;95(4):1036-40
Liver
iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis
Chapoutot C, Esslimani M, Joomaye Z, Ramos J, Perney P, Laurent C, Fabbro-Peray
P, Larrey D, Domergue J, Blanc F Service de Medecine Interne E, Hopital St Eloi,
Montpellier, France. Gut 2000 May;46(5):711-4
Effect
of alcohol consumption on the progression of hepatitis c virus infection and
risk of hepatocellular carcinoma in japanese patients
Khan KN, Yatsuhashi H Institute for Clinical Research, Nagasaki Chuo National
Hospital, WHO Collaborating Center for Reference and Research on Viral Hepatitis,
2-1001-1 Kubara, Omura City, Nagasaki 856, Japan. Alcohol Alcohol 2000 May;35(3):286-295
Positron
emission tomography scanning in the evaluation of hepatocellular carcinoma
Khan MA, Combs CS, Brunt EM, Lowe VJ, Wolverson MK, Solomon H, Collins BT, Di
Bisceglie AM Department of Internal Medicine, Saint Louis University School
of Medicine, MO 63104, USA. J Hepatol 2000 May;32(5):792-7
Evaluation
of the therapeutic effect of transcatheter arterial embolization for hepatocellular
carcinoma
Okusaka T, Okada S, Ueno H, Ikeda M, Yoshimori M, Shimada K, Yamamoto J, Kosuge
T, Yamasaki S, Iwata R, Furukawa H, Moriyama N, Sakamoto M, Hirohashi S Department
of Internal Medicine, National Cancer Center Hospital, Tokyo, Japan. Oncology
2000 May;58(4):293-9
Resection
or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes
based on indicated treatment strategy
Figueras J, Jaurrieta E, Valls C, Ramos E, Serrano T, Rafecas A,
Fabregat J, Torras J Liver Transplant Unit, Ciutat Sanitaria Universitaria Bellvitge,
University of Barcelona, Spain. J Am Coll Surg 2000 May;190(5):580-7
Treatment
of hepatocellular cancer with the long acting somatostatin analog lanreotide
in vitro and in vivo
Raderer M, Hejna MH, Muller C, Kornek GV, Kurtaran A, Virgolini I, Fiebieger
W, Hamilton G, Scheithauer W Department of Internal Medicine I, Division of
Oncology, University of Vienna, A-1090 Vienna, Austria. Int J Oncol 2000 Jun;16(6):1197-201
The
significance of hepatitis B virus DNA detected in hepatocellular carcinoma of
patients with hepatitis C
Shintani Y, Yotsuyanagi H, Moriya K, Fujie H, Tsutsumi T, Takayama T, Makuuchi
M, Kimura S, Koike K Department of Internal Medicine, University of Tokyo, Tokyo,
Japan. Cancer 2000 Jun;88(11):2478-2486
Improved
survival with screening for hepatocellular carcinoma
Wong LL, Limm WM, Severino R, Wong LM Department of Surgery, University of Hawaii
School of Medicine and St Francis Medical Center, Honolulu, HI, USA. Liver Transpl
2000 May;6(3):320-5
Durable
clinical response of refractory hepatocellular carcinoma to orally administered
thalidomide
Patt YZ, Hassan MM, Lozano RD, Ellis LM, Peterson JA, Waugh KA
Department of Gastrointestinal Medical Oncology and Digestive Diseases, The
University of Texas M. D. Anderson Cancer Center, Houston, USA. Am J Clin Oncol
2000 Jun;23(3):319-21
Incidence
of primary cholangiocellular carcinoma of the liver in Japanese patients with
hepatitis C virus-related cirrhosis
Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y,
Arase Y, Murashima N, Chayama K, Kumada H Department of Gastroenterology, Toranomon
Hospital, Tokyo, Japan. Cancer 2000 Jun;88(11):2471-2477
Sensitivity
of commonly available screening tests in detecting hepatocellular carcinoma
in cirrhotic patients undergoing liver transplantation
Gambarin-Gelwan M, Wolf DC, Shapiro R, Schwartz ME, Min AD Department of Medicine,
Mount Sinai Medical Center, New York, New York, USA. Am J Gastroenterol 2000
Jun;95(6):1535-8
Interstitial
laser photocoagulation under ultrasound guidance of liver tumors: results in
104 treated patients
Giorgio A, Tarantino L, de Stefano G, Farella N, Catalano O,
Cusati B, Del Viscovo L, Alaia A, Caturelli E Interventional Ultrasound Service-D,
Cotugno Hospital Naples, Viale colli Aminei 491, 80131, Naples, Italy Eur J
Ultrasound 2000 Jun 1;11(3):181-188
Factors
affecting survival and long-term outcome in the cirrhotic patient undergoing
hepatic resection for hepatocellular carcinoma
Chiappa A, Zbar AP, Audisio RA, Leone BE, Biella F, Staudacher C Department
of General Surgery, European Institute of Oncology, Milan, Italy Eur J Surg
Oncol 2000 Jun;26(4):387-392
Hepatitis
C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and
death
Degos F, Christidis C, Ganne-Carrie N, Farmachidi JP, Degott C, Guettier C,
Trinchet JC, Beaugrand M, Chevret S Service d'Hepatogastro- enterologie, Hopital
Beaujon, Clichy, France. Gut 2000;47:131-136 ( July )
Local
radiotherapy for unresectable hepatocellular carcinoma patients who failed with
transcatheter arterial chemoembolization
Seong J, Park HC, Han KH, Lee DY, Lee JT, Chon CY, Moon YM, Suh CO Department
of Radiation Oncology, Yonsei University Medical College, Seoul, South Korea
Int J Radiat Oncol Biol Phys 2000 Jul 15;47(5):1331-1335
Hepatocellular
carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis
Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, Wyatt JI, Robinson
PJ Departments of Radiology, MRI Unit (J.W., J.A.G., D.J.S., J.A., P.J. R.),
Medical Physics (D.W.), Hepatology (M.H.D.), andPathology (J.I. W.), St James's
University Hospital, Leeds, United Kingdom. Radiology 2000 Jul;216(1):154-62
Neoadjuvant
and adjuvant therapy for operable hepatocellular carcinoma
Chan ES, Chow PK, Tai B, Machin D, Soo K Meta-analysis Division, NMRC Clinical
Trial & Epidemiology Research Unit, Singapore General Hospital, Ministry of
Health Cochrane Database Syst Rev 2000;(2):CD001199
Chi siamo Faq Links Reviews News E-mail Casi clinici